Sponsor content
772 result(s) found, displaying 1 to 10
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LINAJENTA linagliptin 5 mg tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TRAJIPTIN linagliptin 5 mg tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LINAJENTA linagliptin 5 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TRAJIPTIN linagliptin 5 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LINAGLIPTIN ASTRON linagliptin 5 mg tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LINAGLIPTIN INTAS linagliptin 5 mg tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LINAGLIPTIN ASTRON linagliptin 5 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LINAGLIPTIN INTAS linagliptin 5 mg tablet blister pack.
-
Australian public assessment report (AusPar)Dostiva and Dexeva are approved for preventing or managing cancer related bone complications and are biosimilars of Xgeva. Denolia and Deskeltia are approved for treating osteoporosis in men and postmenopausal women, as well as bone loss due to cancer therapies or long term glucocorticoid use and are biosimilars of Prolia.
-
Cancellation by sponsorRequested by Accord Healthcare Pty Ltd